Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection

Cancer

Volumn 95, Issue 1, 2002, Pages 112-118

  Yao, Wei Jen ^a   Wang, Shan Tair ^a   Chow, Nan Haw ^a   Chang, Ting Tsung ^a   Lin, Pin Wen ^a   Tu, Dom Gene ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

fetoprotein; Hepatocellular carcinoma; Recurrence; Tissue polypeptide specific antigen; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; TISSUE POLYPEPTIDE ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER RECURRENCE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNORADIOMETRIC ASSAY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; PATIENT MONITORING; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; TISSUE POLYPEPTIDE ANTIGEN;

EID: 0036645528     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10626     Document Type: Article

References (29)

1. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma - Epidemiologic considerations
2. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients
3. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses
4. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection
5. Prognostic significance of pathologic features of hepatocellular carcinoma. A multivarlate analysis of 278 patients
6. Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis
7. Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?
8. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients
9. Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma
10. Biochemische und morphologische grundlagen von TPA: Fortschritte in richtung auf einem allgemeinen marker für aktive tumoren durch monoklonale karttierung
11. TPS is a useful epithelial proliferation and tumor marker
12. Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9
13. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy
14. Clinical evaluation of serum tissue polypeptide specific antigen in patients with thyroid carcinoma
15. TPS and CA15.3 serum values as a guide for treating and monitoring breast cancer patients
16. Serial tissue polypeptide specific antigen determinations in the follow up of hormone treated carcinoma of the prostate
17. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer
18. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma
19. Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma
20. The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma
21. Clinicopathological correlation of serum tissue polypeptide specific antigen in hepatocellular carcinoma
22. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
23. Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinicopathologic factors and prognosis
24. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma
25. Proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIBI Ki67 in archival material: The role of etiology, disease activity, iron, and lipid peroxidation
26. Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?
27. Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18
28. Tissue polypeptide specific antigen (TPS) detects a specific epitope structure on human cytokeratin